T3011 for advanced melanoma
Treatments studied
Part of Cancer clinical trials.
This trial tests a new treatment, T3011, which is a virus that targets and kills cancer cells while also boosting your immune system. It's for people with advanced melanoma, and the goal is to see if it can shrink tumors and help you live longer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced melanoma that has spread or cannot be removed by surgery
- You have at least one tumor that can be measured on a scan
- You are able to do light daily activities (ECOG 0 or 1)
- Your life expectancy is more than 3 months
- You do not have serious heart problems, an autoimmune disease, or an active infection needing IV treatment
- You are willing to use effective birth control during and for 6 months after the study (if you or your partner could become pregnant)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called LM103 for people with advanced melanoma who have already tried several standard treatments, including immunotherapy. The goal is to see if LM103 can help shrink tumors when other treatments have stopped working.
This early-phase trial tests GC101 TIL, a treatment made from your own melanoma tumor cells, for advanced melanoma. It may help the immune system better fight the cancer after standard treatments have already stopped working or if none are available.
This trial tests a new drug (BT02) for advanced melanoma that has stopped responding to earlier treatments. The goal is to see if it is safe and may help shrink tumors.
This trial tests a new treatment called GC101 TIL for people with advanced melanoma that has not responded to other therapies. It involves taking immune cells from a tumor, growing them in a lab, and giving them back to fight the cancer.
This trial tests a new drug called PRJ1-3024 for people with advanced melanoma that has not responded to standard treatment. The goal is to see if the drug can shrink tumors or slow the cancer's growth.
This trial tests a new treatment using your own immune cells (T cells) that are modified to find and attack cancer cells with a specific genetic change (KRAS G12V or G12D). It is for people with advanced cancer that has not responded to standard treatments.
Hear when a new Advanced Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.